Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INV-102 in Moderate Symptomatic Dry Eye Disease
NCT05586152Phase 2Completed
- Sponsor
- Invirsa
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of INV-102 in dry eye disease (DED), sponsored by Invirsa. Started Aug 2022; status: completed.
02
Drugs
INV-102
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05586152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586152.